MedPath

Feasibility of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors

Not Applicable
Completed
Conditions
Fatigue
Sleep Disturbance
Circadian Dysregulation
Interventions
Device: Morning bright light therapy
Device: Dim light
Registration Number
NCT02954809
Lead Sponsor
State University of New York at Buffalo
Brief Summary

The purpose of this study is to determine the feasibility of a morning bright light therapy intervention for fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.

Detailed Description

A randomized controlled trial to test the effects of morning bright light therapy on fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  • Stage I-III Non-small cell lung cancer survivors
  • Must be at >6-weeks and < 3 years post-surgical resection
  • Must have diagnosis fatigue and/or sleep disturbances
Exclusion Criteria
  • Individuals clinically unstable.
  • Mania, Bipolar disease or seizure disorder
  • Macular degeneration or glaucoma.
  • Currently receiving chemotherapy or radiation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ExperimentalMorning bright light therapyExposure to morning bright light therapy delivered with Green-Blue Re-Timer glasses for 30 minutes in the morning during one week.
Attention ControlDim lightExposure to dim light delivered with Red-Yellow Re-Timer glasses for 30 minutes in the morning during one week.
Primary Outcome Measures
NameTimeMethod
Study CompletionBaseline

The percentage of participants recruited that completed the study

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

SUNY University at Buffalo

🇺🇸

Buffalo, New York, United States

© Copyright 2025. All Rights Reserved by MedPath